Supplementary table I- Efficacy and tolerance of dupilumab in obese patients with moderate-to-severe atopic dermatitis. Dupuis et al
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://data.mendeley.com/datasets/d23bwhdnkh
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary Table I: Adverse events during the follow-up period in patients treated with dupilumab.
创建时间：
2023-12-18
